Integrated Wealth Concepts LLC Sorrento Therapeutics, Inc. Transaction History

Integrated Wealth Concepts LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $1,812 - $3,456	1,200 Added 5.69%	22,281 $35,000
Q2 2022 Aug 08, 2022	BUY	$1.24 - $2.33 $3,720 - $6,990	3,000 Added 16.59%	21,081 $42,000
Q1 2022 May 12, 2022	BUY	$2.0 - $4.9 $2,560 - $6,272	1,280 Added 7.62%	18,081 $42,000
Q4 2021 Feb 15, 2022	BUY	$4.65 - $7.23 $1,906 - $2,964	410 Added 2.5%	16,801 $78,000
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $25,194 - $37,366	-3,400 Reduced 17.18%	16,391 $125,000
Q2 2021 Aug 13, 2021	BUY	$6.35 - $10.0 $1,270 - $2,000	200 Added 1.02%	19,791 $192,000
Q1 2021 May 13, 2021	SELL	$7.03 - $16.51 $6,327 - $14,859	-900 Reduced 4.39%	19,591 $162,000
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $5,760 - $11,950	1,000 Added 5.13%	20,491 $140,000
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $98,720 - $301,120	-16,000 Reduced 45.08%	19,491 $217,000
Q2 2020 Jul 30, 2020	SELL	$1.73 - $6.76 $126,117 - $492,804	-72,900 Reduced 67.26%	35,491 $223,000
Q4 2019 Feb 20, 2020	SELL	$1.45 - $4.17 $50,750 - $145,950	-35,000 Reduced 24.41%	108,391 $366,000
Q2 2018 Jul 27, 2018	BUY	$4.75 - $8.0 $681,107 - $1.15 Million	143,391 New	143,391 $1.04 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Wealth Concepts LLC with notifications on news.